Hipolin board to consider FY26 results on May 29

0 min read     Updated on 23 May 2026, 06:41 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Hipolin Limited will hold a board meeting on May 29, 2026, to approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to record the statutory auditor's report.

powered bylight_fuzz_icon
41087505

*this image is generated using AI for illustrative purposes only.

Hipolin Limited has announced that its board of directors will meet on Friday, May 29, 2026. The primary agenda of the meeting is to consider and approve the company's financial performance for the fiscal year ending March 31, 2026.

Agenda for the Meeting

The board will deliberate on the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. In accordance with Regulation 33 of the listing regulations, the directors will also take on record the audit report presented by the statutory auditor.

Regulatory Compliance

The notice regarding the board meeting was issued in compliance with Regulation 29(1)(a) of the SEBI (LODR) Regulations, 2015. The company has communicated this schedule to the stock exchanges to ensure timely dissemination of information to the shareholders.

Meeting Detail Information
Date May 29, 2026
Purpose Consideration of Audited Financial Results
Period Quarter and Year ended March 31, 2026
Regulation SEBI (LODR) Regulations, 2015

Historical Stock Returns for Hipolin

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-3.95%+20.62%+40.64%-10.75%+158.38%

How does Hipolin Limited's expected FY2026 revenue and profit growth compare to its industry peers in the fast-moving consumer goods or chemical sector?

Will the board consider announcing a dividend or any capital allocation strategy alongside the FY2026 financial results approval?

Are there any pending regulatory investigations or audit qualifications that could impact the clean approval of Hipolin's FY2026 standalone and consolidated results?

Hipolin Limited Submits SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 11 Apr 2026, 12:48 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Hipolin Limited filed its compliance certificate under SEBI Regulation 74(5) for Q4FY26 ended March 31, 2026, with the Bombay Stock Exchange on April 10, 2026. The submission was made by Company Secretary Anjali Maheshwari and supported by a confirmation certificate from registrar MUFG Intime India Private Limited, verifying proper handling of dematerialisation processes during the quarter.

powered bylight_fuzz_icon
37394322

*this image is generated using AI for illustrative purposes only.

Hipolin Limited has submitted its quarterly compliance certificate under SEBI regulations to the Bombay Stock Exchange, fulfilling mandatory regulatory requirements for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company filed its compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 on April 10, 2026. Company Secretary and Compliance Officer Anjali Maheshwari signed the submission, which was addressed to the Listing Department of Bombay Stock Exchange Limited.

Filing Details: Information
Regulation: SEBI Regulation 74(5)
Quarter Ended: March 31, 2026
Filing Date: April 10, 2026
Scrip Code: 530853
Filed By: Anjali Maheshwari, Company Secretary

Registrar Confirmation

MUFG Intime India Private Limited, serving as Hipolin's Registrar and Transfer Agent, issued a confirmation certificate dated April 1, 2026. The certificate was signed by Ashok Shetty, Sr. Vice President-Corporate Registry, confirming the company's compliance with dematerialisation requirements.

The registrar confirmed that securities received from depository participants for dematerialisation during the quarter were properly processed and that all security certificates were mutilated and cancelled after due verification. The confirmation also verified that depositories' names were substituted in the register of members as registered owners within prescribed timelines.

Company Information

Hipolin Limited operates from its registered office located at Survey No. 2/2, Behind Safeexpress Logistic, Changodar, Dist. Ahmedabad 382213. The company holds CIN L24240GJ1994PLCO21719 and maintains its listing on the Bombay Stock Exchange under scrip code 530853.

MUFG Intime India Details

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the registrar and transfer agent. The company operates from its registered address at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083, with CIN U67190MH1999PTC118368.

Historical Stock Returns for Hipolin

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-3.95%+20.62%+40.64%-10.75%+158.38%

What operational or financial challenges might Hipolin Limited face in maintaining consistent regulatory compliance as SEBI requirements evolve?

How could the recent change from Link Intime to MUFG Intime India as registrar impact Hipolin's shareholder services and compliance processes?

What market developments in Hipolin's industry sector could affect its ability to meet future quarterly compliance deadlines?

More News on Hipolin

1 Year Returns:-10.75%